Index
1 Parenteral Dosage Form Market Overview
1.1 Product Overview and Scope of Parenteral Dosage Form
1.2 Parenteral Dosage Form Segment by Type
1.2.1 Global Parenteral Dosage Form Market Value Comparison by Type (2023-2029)
1.2.2 Emulsions for Injection
1.2.3 Powders for Injection
1.2.4 Gels for Injection
1.3 Parenteral Dosage Form Segment by Application
1.3.1 Global Parenteral Dosage Form Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Parenteral Dosage Form Market Size Estimates and Forecasts
1.4.1 Global Parenteral Dosage Form Revenue 2018-2029
1.4.2 Global Parenteral Dosage Form Sales 2018-2029
1.4.3 Global Parenteral Dosage Form Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Parenteral Dosage Form Market Competition by Manufacturers
2.1 Global Parenteral Dosage Form Sales Market Share by Manufacturers (2018-2023)
2.2 Global Parenteral Dosage Form Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Parenteral Dosage Form Average Price by Manufacturers (2018-2023)
2.4 Global Parenteral Dosage Form Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Parenteral Dosage Form, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Parenteral Dosage Form, Product Type & Application
2.7 Parenteral Dosage Form Market Competitive Situation and Trends
2.7.1 Parenteral Dosage Form Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Parenteral Dosage Form Players Market Share by Revenue
2.7.3 Global Parenteral Dosage Form Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Parenteral Dosage Form Retrospective Market Scenario by Region
3.1 Global Parenteral Dosage Form Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Parenteral Dosage Form Global Parenteral Dosage Form Sales by Region: 2018-2029
3.2.1 Global Parenteral Dosage Form Sales by Region: 2018-2023
3.2.2 Global Parenteral Dosage Form Sales by Region: 2024-2029
3.3 Global Parenteral Dosage Form Global Parenteral Dosage Form Revenue by Region: 2018-2029
3.3.1 Global Parenteral Dosage Form Revenue by Region: 2018-2023
3.3.2 Global Parenteral Dosage Form Revenue by Region: 2024-2029
3.4 North America Parenteral Dosage Form Market Facts & Figures by Country
3.4.1 North America Parenteral Dosage Form Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Parenteral Dosage Form Sales by Country (2018-2029)
3.4.3 North America Parenteral Dosage Form Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Parenteral Dosage Form Market Facts & Figures by Country
3.5.1 Europe Parenteral Dosage Form Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Parenteral Dosage Form Sales by Country (2018-2029)
3.5.3 Europe Parenteral Dosage Form Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Parenteral Dosage Form Market Facts & Figures by Country
3.6.1 Asia Pacific Parenteral Dosage Form Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Parenteral Dosage Form Sales by Country (2018-2029)
3.6.3 Asia Pacific Parenteral Dosage Form Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Parenteral Dosage Form Market Facts & Figures by Country
3.7.1 Latin America Parenteral Dosage Form Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Parenteral Dosage Form Sales by Country (2018-2029)
3.7.3 Latin America Parenteral Dosage Form Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Parenteral Dosage Form Market Facts & Figures by Country
3.8.1 Middle East and Africa Parenteral Dosage Form Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Parenteral Dosage Form Sales by Country (2018-2029)
3.8.3 Middle East and Africa Parenteral Dosage Form Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Parenteral Dosage Form Sales by Type (2018-2029)
4.1.1 Global Parenteral Dosage Form Sales by Type (2018-2023)
4.1.2 Global Parenteral Dosage Form Sales by Type (2024-2029)
4.1.3 Global Parenteral Dosage Form Sales Market Share by Type (2018-2029)
4.2 Global Parenteral Dosage Form Revenue by Type (2018-2029)
4.2.1 Global Parenteral Dosage Form Revenue by Type (2018-2023)
4.2.2 Global Parenteral Dosage Form Revenue by Type (2024-2029)
4.2.3 Global Parenteral Dosage Form Revenue Market Share by Type (2018-2029)
4.3 Global Parenteral Dosage Form Price by Type (2018-2029)
5 Segment by Application
5.1 Global Parenteral Dosage Form Sales by Application (2018-2029)
5.1.1 Global Parenteral Dosage Form Sales by Application (2018-2023)
5.1.2 Global Parenteral Dosage Form Sales by Application (2024-2029)
5.1.3 Global Parenteral Dosage Form Sales Market Share by Application (2018-2029)
5.2 Global Parenteral Dosage Form Revenue by Application (2018-2029)
5.2.1 Global Parenteral Dosage Form Revenue by Application (2018-2023)
5.2.2 Global Parenteral Dosage Form Revenue by Application (2024-2029)
5.2.3 Global Parenteral Dosage Form Revenue Market Share by Application (2018-2029)
5.3 Global Parenteral Dosage Form Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Ashland
6.1.1 Ashland Corporation Information
6.1.2 Ashland Description and Business Overview
6.1.3 Ashland Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Ashland Parenteral Dosage Form Product Portfolio
6.1.5 Ashland Recent Developments/Updates
6.2 Tepnel Pharma Services
6.2.1 Tepnel Pharma Services Corporation Information
6.2.2 Tepnel Pharma Services Description and Business Overview
6.2.3 Tepnel Pharma Services Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Tepnel Pharma Services Parenteral Dosage Form Product Portfolio
6.2.5 Tepnel Pharma Services Recent Developments/Updates
6.3 Ascendia Pharmaceuticals
6.3.1 Ascendia Pharmaceuticals Corporation Information
6.3.2 Ascendia Pharmaceuticals Description and Business Overview
6.3.3 Ascendia Pharmaceuticals Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ascendia Pharmaceuticals Parenteral Dosage Form Product Portfolio
6.3.5 Ascendia Pharmaceuticals Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Thermo Fisher Scientific Parenteral Dosage Form Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 ProJect Pharmaceutics
6.5.1 ProJect Pharmaceutics Corporation Information
6.5.2 ProJect Pharmaceutics Description and Business Overview
6.5.3 ProJect Pharmaceutics Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.5.4 ProJect Pharmaceutics Parenteral Dosage Form Product Portfolio
6.5.5 ProJect Pharmaceutics Recent Developments/Updates
6.6 Lonza
6.6.1 Lonza Corporation Information
6.6.2 Lonza Description and Business Overview
6.6.3 Lonza Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Lonza Parenteral Dosage Form Product Portfolio
6.6.5 Lonza Recent Developments/Updates
6.7 BOC Sciences
6.6.1 BOC Sciences Corporation Information
6.6.2 BOC Sciences Description and Business Overview
6.6.3 BOC Sciences Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BOC Sciences Parenteral Dosage Form Product Portfolio
6.7.5 BOC Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Parenteral Dosage Form Industry Chain Analysis
7.2 Parenteral Dosage Form Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Parenteral Dosage Form Production Mode & Process
7.4 Parenteral Dosage Form Sales and Marketing
7.4.1 Parenteral Dosage Form Sales Channels
7.4.2 Parenteral Dosage Form Distributors
7.5 Parenteral Dosage Form Customers
8 Parenteral Dosage Form Market Dynamics
8.1 Parenteral Dosage Form Industry Trends
8.2 Parenteral Dosage Form Market Drivers
8.3 Parenteral Dosage Form Market Challenges
8.4 Parenteral Dosage Form Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer